Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00331760 · OUTCOME

Rate of Distant Metastases at Five Years

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery · Source last updated 2019-02-26

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
From registration to five years

What was measured

Distant Metastases failure time is defined as time from registration to date of distant disease, death without distant metastases (competing risk), or last known follow-up (censored) and is estimated by the cumulative incidence method. Para-aortic nodal disease is considered to be distant disease for a cervical primary, but not for an endometrial primary.

Analysis population: Eligible patients who started study treatment

Groups in this outcome

Endometrial Cancer: IMRT

Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)

Cervical Cancer: IMRT + Chemotherapy (Cisplatin)

Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Endometrial Cancer: IMRT43
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)40

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Endometrial Cancer: IMRT7Not reported217Not reported
Cervical Cancer: IMRT + Chemotherapy (Cisplatin)14Not reported527Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2
        upper Limit
        17
        value
        7
      2. group Id
        OG001
        lower Limit
        5
        upper Limit
        27
        value
        14
denoms
  1. counts
    1. group Id
      OG000
      value
      43
    2. group Id
      OG001
      value
      40
    units
    Participants
description
Distant Metastases failure time is defined as time from registration to date of distant disease, death without distant metastases (competing risk), or last known follow-up (censored) and is estimated by the cumulative incidence method. Para-aortic nodal disease is considered to be distant disease for a cervical primary, but not for an endometrial primary.
dispersion Type
95% Confidence Interval
groups
  1. description
    Endometrial Cancer patients receive Intensity Modulated Radiation Therapy (IMRT)
    id
    OG000
    title
    Endometrial Cancer: IMRT
  2. description
    Cervical patients receive Intensity Modulated Radiation Therapy (IMRT) + Chemotherapy (cisplatin)
    id
    OG001
    title
    Cervical Cancer: IMRT + Chemotherapy (Cisplatin)
param Type
NUMBER
population Description
Eligible patients who started study treatment
reporting Status
POSTED
time Frame
From registration to five years
title
Rate of Distant Metastases at Five Years
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice